Etesian Wealth Advisors, Inc.

Position in ABBV — AbbVie Inc.

CIK 1997586 West Linn, OR

Position in ABBV

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,383,030

+$313,613 QoQ

Shares Held

9,470

-0.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.64%

of 13F equity value

Holder Rank

#1,829

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Etesian Wealth Advisors, Inc. holds $8,238,349 across 4 Drug Manufacturers - General names. ABBV ranks #2 (28.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,360	$4,030,085
2	ABBV	AbbVie Inc. This page	9,470	$2,383,030
3	GILD	Gilead Sciences, Inc.	9,721	$1,228,151
4	JNJ	Johnson & Johnson	2,351	$597,083

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,383,030	9,470	-0.5%	Shares	Sole	2026-07-23
2026-03-31	$2,069,417	9,515	-0.2%	Shares	Sole	2026-04-23
2025-12-31	$2,177,738	9,531	-2.2%	Shares	Sole	2026-02-11
2025-09-30	$2,255,431	9,741	-0.8%	Shares	Sole	2025-10-23
2025-06-30	$1,823,159	9,822	-2.4%	Shares	Sole	2025-07-24
2025-03-31	$2,107,561	10,059	-0.2%	Shares	Sole	2025-04-24
2024-12-31	$1,791,926	10,084	+0.0%	Shares	Sole	2025-01-27
2024-09-30	$1,990,993	10,082	-0.4%	Shares	Sole	2024-10-18
2024-06-30	$1,736,983	10,127	+0.7%	Shares	Sole	2024-07-25
2024-03-31	$1,831,926	10,060	-9.7%	Shares	Sole	2024-04-15
2023-12-31	$1,726,365	11,140	-2.6%	Shares	Sole	2024-01-16
2023-09-30	$1,704,352	11,434	-0.4%	Shares	Sole	2024-01-16
2023-06-30	$1,546,969	11,482	+0.0%	Shares	Sole	2024-01-16
2023-03-31	$1,829,567	11,480	-1.5%	Shares	Sole	2024-01-16
2022-12-31	$1,882,594	11,649	—	Shares	Sole	2024-01-16
No filing history on record for this holder in this stock.